Results 191 to 200 of about 57,892 (307)

The pharmacology of gepants in migraine: A scoping review on mechanisms, clinical applications, and combination strategies

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Background Calcitonin gene‐related peptide (CGRP) is a key mediator in migraine pathophysiology, and the development of gepants, novel CGRP receptor antagonists, has expanded therapeutic options for both acute and preventive treatment. This scoping review aims to synthesize current evidence on the pharmacology, clinical applications, safety ...
Luigi Francesco Iannone   +5 more
wiley   +1 more source

Cervical musculoskeletal function is variable in tension‐type headache: A cluster analysis

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives This study was conducted to (1) consider the causes of neck pain in tension‐type headache (TTH) by investigating how the patients with TTH, idiopathic neck pain (INP), and healthy controls group together based on the presence of cervical musculoskeletal dysfunction; and (2) determine any differences in TTH features, pain sensitivity,
Chalomjai Pensri   +5 more
wiley   +1 more source

Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION Trial. [PDF]

open access: yesNeurology
Jensen RH   +13 more
europepmc   +1 more source

A patient‐centered conceptual model and measurement framework for migraine experience developed by the Migraine Clinical Outcome Assessment System

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To develop a comprehensive, evidence‐based, patient‐centered conceptual model of migraine and to derive a measurement framework for the development or selection of clinical outcome assessments used in clinical trials of treatments for migraine.
Rikki Mangrum   +6 more
wiley   +1 more source

Aseptic meningitis due to intravenous immunoglobulin therapy (IVIG) in therapy‐refractory pyoderma gangraenosum

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Katharina A. Kälber   +3 more
wiley   +1 more source

Efficacy of a multidisciplinary 5‐day headache day‐clinic program: A prospective quasi‐experimental pre–post study in primary headache disorders

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
xxxx Abstract Objective To evaluate the effects of a short, structured multimodal day‐clinic program on health‐related quality of life and disability in patients with primary headache disorders. Background Although monoclonal antibodies targeting the calcitonin gene‐related peptide (CGRP) pathway have substantially advanced migraine prophylaxis, a ...
Nadja Fiebig   +7 more
wiley   +1 more source

Optimizing Chronic Migraine Care: The Impact of Advanced Practice Nurse Involvement in OnabotulinumtoxinA Administration. [PDF]

open access: yesRev Neurol
Gine-Cipres E   +6 more
europepmc   +1 more source

Suzetrigine as a novel treatment for headache disorders: A case series

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Suzetrigine is a selective voltage‐gated sodium channel blocker that was recently approved by the US Food and Drug Administration for the treatment of acute pain. We retrospectively evaluated the efficacy and tolerability of suzetrigine for the treatment of different headache disorders in patients refractory to standard treatments in an ...
Molly Fensterwald   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy